Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s displayed ClinicalTrials.gov revision label has been updated from v3.5.2 to v3.5.3, indicating a new software release. No study-specific details on the record history table appear to be changed.
    Difference
    0.1%
    Check dated 2026-04-24T06:37:28.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision history updated: a new entry Revision: v3.5.2 was added, and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:48:56.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision v3.5.0 has been added and v3.4.3 removed in the study record history.
    Difference
    0.1%
    Check dated 2026-03-19T05:20:52.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision history now includes v3.4.3 and removes v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T01:05:17.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new revision entry, v3.4.2, was added to the study record history; a government-funding operating-status notice and the prior revision note v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T14:26:08.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and current operating status was added, directing users to official status sources. The revision tag was updated to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.7%
    Check dated 2026-02-04T10:40:31.000Z thumbnail image

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.